AiSci: On the commercialization of biopharmaceutical modalities - PANews
... an AI model that can efficiently generate miniature antibodies (called VHHs or nanobodies) for specific targets. AiSci: On the commercialization ...
Read the original at panewslab.com ↗
- Topics
- Healthcare
- Tracked via
- “An AI Model that”